Potential of osteopontin in the management of epithelial ovarian cancer
Osteopontin (sOPN) is a promising blood tumour marker for detecting epithelial ovarian cancer (EOC). However, other clinical uses of sOPN as a tumour marker in EOC are still lacking. Since sOPN concentrations in serum are not associated with those in ascites, we compared clinical value of sOPN conce...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-01-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/raon-2019-0003 |
_version_ | 1797848546963095552 |
---|---|
author | Cerne Katarina Hadzialjevic Benjamin Skof Erik Verdenik Ivan Kobal Borut |
author_facet | Cerne Katarina Hadzialjevic Benjamin Skof Erik Verdenik Ivan Kobal Borut |
author_sort | Cerne Katarina |
collection | DOAJ |
description | Osteopontin (sOPN) is a promising blood tumour marker for detecting epithelial ovarian cancer (EOC). However, other clinical uses of sOPN as a tumour marker in EOC are still lacking. Since sOPN concentrations in serum are not associated with those in ascites, we compared clinical value of sOPN concentrations in the two body fluids. |
first_indexed | 2024-04-09T18:30:24Z |
format | Article |
id | doaj.art-f947a85790224329af937ef4e327882f |
institution | Directory Open Access Journal |
issn | 1581-3207 |
language | English |
last_indexed | 2024-04-09T18:30:24Z |
publishDate | 2019-01-01 |
publisher | Sciendo |
record_format | Article |
series | Radiology and Oncology |
spelling | doaj.art-f947a85790224329af937ef4e327882f2023-04-11T17:19:27ZengSciendoRadiology and Oncology1581-32072019-01-0153110511510.2478/raon-2019-0003raon-2019-0003Potential of osteopontin in the management of epithelial ovarian cancerCerne Katarina0Hadzialjevic Benjamin1Skof Erik2Verdenik Ivan3Kobal Borut4Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University Ljubljana, Ljubljana, SloveniaInstitute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University Ljubljana, Ljubljana, SloveniaDepartment of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, SloveniaDepartment of Gynaecology, Division of Gynaecology and Obstetrics, University Medical Centre Ljubljana, Ljubljana, SloveniaDepartment of Gynaecology, Division of Gynaecology and Obstetrics, University Medical Centre Ljubljana, Ljubljana, SloveniaOsteopontin (sOPN) is a promising blood tumour marker for detecting epithelial ovarian cancer (EOC). However, other clinical uses of sOPN as a tumour marker in EOC are still lacking. Since sOPN concentrations in serum are not associated with those in ascites, we compared clinical value of sOPN concentrations in the two body fluids.https://doi.org/10.2478/raon-2019-0003advanced ovarian cancerosteopontinserumascites |
spellingShingle | Cerne Katarina Hadzialjevic Benjamin Skof Erik Verdenik Ivan Kobal Borut Potential of osteopontin in the management of epithelial ovarian cancer Radiology and Oncology advanced ovarian cancer osteopontin serum ascites |
title | Potential of osteopontin in the management of epithelial ovarian cancer |
title_full | Potential of osteopontin in the management of epithelial ovarian cancer |
title_fullStr | Potential of osteopontin in the management of epithelial ovarian cancer |
title_full_unstemmed | Potential of osteopontin in the management of epithelial ovarian cancer |
title_short | Potential of osteopontin in the management of epithelial ovarian cancer |
title_sort | potential of osteopontin in the management of epithelial ovarian cancer |
topic | advanced ovarian cancer osteopontin serum ascites |
url | https://doi.org/10.2478/raon-2019-0003 |
work_keys_str_mv | AT cernekatarina potentialofosteopontininthemanagementofepithelialovariancancer AT hadzialjevicbenjamin potentialofosteopontininthemanagementofepithelialovariancancer AT skoferik potentialofosteopontininthemanagementofepithelialovariancancer AT verdenikivan potentialofosteopontininthemanagementofepithelialovariancancer AT kobalborut potentialofosteopontininthemanagementofepithelialovariancancer |